- Today
- Holidays
- Birthdays
- Reminders
- Cities
- Atlanta
- Austin
- Baltimore
- Berwyn
- Beverly Hills
- Birmingham
- Boston
- Brooklyn
- Buffalo
- Charlotte
- Chicago
- Cincinnati
- Cleveland
- Columbus
- Dallas
- Denver
- Detroit
- Fort Worth
- Houston
- Indianapolis
- Knoxville
- Las Vegas
- Los Angeles
- Louisville
- Madison
- Memphis
- Miami
- Milwaukee
- Minneapolis
- Nashville
- New Orleans
- New York
- Omaha
- Orlando
- Philadelphia
- Phoenix
- Pittsburgh
- Portland
- Raleigh
- Richmond
- Rutherford
- Sacramento
- Salt Lake City
- San Antonio
- San Diego
- San Francisco
- San Jose
- Seattle
- Tampa
- Tucson
- Washington
Rockville Today
By the People, for the People
CPAP Device Market Projected to Exceed $15 Billion by 2036
AI-Enabled Sleep Therapy Fuels Transformative Growth in Global CPAP Device Market
Published on Feb. 11, 2026
Got story updates? Submit your updates here. ›
The global Continuous Positive Airway Pressure (CPAP) device market is poised for significant growth over the next decade, with the broader sleep apnea devices market projected to reach $15.1 billion by 2036. This surge is driven by the rising prevalence of Obstructive Sleep Apnea (OSA), increasing global obesity rates, and advancements in smart therapeutic technologies.
Why it matters
The CPAP device market is undergoing a transformative shift, moving from standalone hardware to integrated digital health ecosystems. This transition is driven by the growing demand for home-based care and the integration of artificial intelligence (AI) in sleep therapy. As healthcare providers focus on remote patient monitoring, CPAP manufacturers are adapting their offerings to meet the evolving needs of the market.
The details
The next decade will see CPAP devices evolve from noisy, cumbersome bedside units to ultra-quiet, travel-friendly, and cloud-connected systems. Industry leaders like ResMed, Koninklijke Philips N.V., and Fisher & Paykel Healthcare continue to dominate the premium segment, while agile players such as BMC Medical and Inspire Medical Systems are capturing significant share in emerging markets and alternative therapies. The market is also witnessing a transition from fixed-pressure CPAP to Auto-adjusting Positive Airway Pressure (APAP) and AI-driven adherence platforms that provide real-time coaching.
- The forecast period (2026–2036) marks the transition from clinical-centric diagnosis to consumer-led home sleep testing (HST).
- The global CPAP device market is projected to reach $15.1 billion by 2036, expanding at a CAGR of 7.5% from 2026.
The players
ResMed
A leading provider of CPAP devices and a dominant player in the premium segment of the market.
Koninklijke Philips N.V.
A multinational conglomerate and a major manufacturer of CPAP devices, competing in the premium segment.
Fisher & Paykel Healthcare
A prominent manufacturer of CPAP devices, known for its premium-quality products.
BMC Medical
An agile player in the CPAP device market, capturing significant share in emerging markets and alternative therapies.
Inspire Medical Systems
An innovative company developing alternative sleep apnea therapies, including CPAP devices.
What’s next
The forecast period (2026–2036) marks the transition from clinical-centric diagnosis to consumer-led home sleep testing (HST), which is expected to drive further growth in the CPAP device market.
The takeaway
The CPAP device market is undergoing a transformative shift, driven by the integration of AI-enabled technologies and the growing demand for home-based care. This transition is expected to improve patient compliance and drive the market towards a more personalized and connected sleep therapy ecosystem.
